The DOI matches its Crossref record; 135 of the 137 references it cites were found in a registry or an index.
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
Open accessAbstract
Hepatic cirrhosis and hepatocellular carcinoma (HCC) are the most common causes of death in patients with chronic liver disease. Chronic liver injury of virtually any etiology triggers inflammatory and wound-healing responses that in the long run promote the development of hepatic fibrosis and HCC. Here, we review the role of the transcription factor nuclear factor-κB (NF-κB), a master regulator of inflammation and cell death, in the development of hepatocellular injury, liver fibrosis and HCC, with a particular focus on the role of NF-κB in different cellular compartments of the liver. We propose that NF-κB acts as a central link between hepatic injury, fibrosis and HCC, and that it may represent a target for the prevention or treatment of liver fibrosis and HCC. However, NF-κB acts as a two-edged sword and inhibition of NF-κB may not only exert beneficial effects but also negatively impact hepatocyte viability, especially when NF-κB inhibition is pronounced. Finding appropriate targets or identifying drugs that either exert only a moderate effect on NF-κB activity or that can be specifically delivered to nonparenchymal cells will be essential to avoid the increase in liver injury associated with complete NF-κB blockade in hepatocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the decisive factor is that NF-κB-activation additionally causes a significantly increased resistance against apoptosis in aHSCs.[21]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Activators and Target Genes of Rel/NF-кB Transcription Factors
Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Cited by
Sorted by citations
Items 101–200 of 999
Gan, F., Liu, Q., Liu, Y., Huang, D. W., Pan, C., Song, S., & Huang, K. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.047 · Cited by 113
Kim, J. E., Clark, R. M., Park, Y., Lee, J., & Fernández, M. L. (2012) · Nutrition Research and Practice · doi:10.4162/nrp.2012.6.2.113 · Cited by 112
Li, R., Xu, L., Liang, T., Li, Y., Zhang, S., & Duan, X. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.059 · Cited by 111
GDF15 deficiency exacerbates chronic alcohol- and carbon tetrachloride-induced liver injury
Chung, H. K., Kim, J. T., Kim, H.-W., Kwon, M., Kim, S. Y., Shong, M., Kim, K. S., & Yi, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-17574-w · Cited by 111
CCN1 induces hepatic ductular reaction through integrin αvβ5–mediated activation of NF-κB
Kim, K.-H., Chen, C.-C., Alpini, G., & Lau, L. F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79327 · Cited by 109
Protein complex scaffolding predicted as a prevalent function of long non-coding RNAs
Ribeiro, D. M., Zanzoni, A., Cipriano, A., Ponti, R. D., Spinelli, L., Ballarino, M., Bozzoni, I., Tartaglia, G. G., & Brun, C. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1169 · Cited by 112
Biyu, Z., Su, M., Chen, Q., Chang, Q., Wang, W., & Li, H. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.02.018 · Cited by 107
Yang, F., Luo, L., Zhu, Z., Zhou, X., Wang, Y., Xue, J., Zhang, J., Cai, X., Chen, Z.-L., Ma, Q., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00929 · Cited by 107
Nowak, A. J., & Relja, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249407 · Cited by 112
Role of Oxidative Stress in Liver Disorders
Conde de la Rosa, L., Goicoechea, L., Torres, S., Garcia-Ruiz, C., & Fernandez-Checa, J. C. (2022) · Livers · doi:10.3390/livers2040023 · Cited by 107
Roderburg, C., Mollnow, T., Bongaerts, B. W. C., Elfimova, N., Cardenas, D. V., Janssen, K., Zimmermann, H. W., Koch, A. H., Vucur, M., Luedde, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032999 · Cited by 105
Self-citationPhysiological and Immune Functions of Punicalagin
Venusová, E., Kolesárová, A., Horký, P., & Sláma, P. (2021) · Nutrients · doi:10.3390/nu13072150 · Cited by 110
Zhang, H., Yu, C., Jiang, Y.-P., Peng, C. Y., He, K., Tang, J., & Xin, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046574 · Cited by 103
Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
Goto, K., Suarez, A. A. R., Wrensch, F., Baumert, T. F., & Lupberger, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093057 · Cited by 108
Hepatic stellate cells: central modulators of hepatic carcinogenesis
Thompson, A., Conroy, K. P., & Henderson, N. C. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0291-5 · Cited by 103
Peng, Z., Gong, X., Yang, Y., Huang, L., Zhang, Q., Zhang, P., Wan, R., & Zhang, B. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.09.022 · Cited by 101
Pharmacological activities and pharmacokinetics of liquiritin: A review
Qin, J., Chen, J., Peng, F., Sun, C., Lei, Y., Chen, G., Li, G., Yin, Y., Lin, Z., Wu, L., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115257 · Cited by 101
Sung, Y., Liu, Y.-C., Chao, P., Chang, C.-C., Jin, P.-R., Lin, T.-T., Lin, J.-A., Cheng, H., Wang, J., Lai, C. P., et al. (2017) · Theranostics · doi:10.7150/thno.21168 · Cited by 102
Aljobaily, N. A., Viereckl, M. J., Hydock, D. S., Aljobaily, H., Wu, T.-Y., Busekrus, R. B., Jones, B., Alberson, J., & Han, Y. (2020) · Nutrients · doi:10.3390/nu13010041 · Cited by 101
Chang, F.-M., Reyna, S. M., Granados, J. C., Wei, S., Innis‐Whitehouse, W., Maffi, S. K., Rodriguez, E., Slaga, T. J., & Short, J. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.397703 · Cited by 99
Kofahi, H. M., Taylor, N., Hirasawa, K., Grant, M. D., & Russell, R. S. (2016) · Scientific Reports · doi:10.1038/srep37433 · Cited by 99
Domitrović, R., Jakovac, H., Vasiljev, V., Šain, I., Romić, Ž., & Rahelić, D. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.12.005 · Cited by 99
Involvement of DNA Damage Response Pathways in Hepatocellular Carcinoma
Yang, S., Chang, C.-W., Wei, R., Shiue, Y., Wang, S., & Yeh, Y. (2014) · BioMed Research International · doi:10.1155/2014/153867 · Cited by 101
Zhao, P., & Saltiel, A. R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011356 · Cited by 106
Goldstein, I., Paakinaho, V., Baek, S., Sung, M.-H., & Hager, G. L. (2017) · Nature Communications · doi:10.1038/s41467-017-02055-5 · Cited by 97
Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind
Isaguliants, M. G., Олеговна, Б. Е., Avdoshina, D., Kondrashova, A., Chiodi, F., & Palefsky, J. M. (2021) · Cancers · doi:10.3390/cancers13020305 · Cited by 100
Jia, R., Gu, Z., He, Q., Du, J., Cao, L., Jeney, G., Xu, P., & Yin, G. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.07.080 · Cited by 94
Abdu, S. B. S., Juaid, N., Amin, A., Moulay, M., & Miled, N. (2022) · Molecules · doi:10.3390/molecules27228082 · Cited by 98
Huang, X., Zhao, W., & Huang, W. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.117 · Cited by 98
Xu, P., Zhang, Y., Liu, Y., Yuan, Q., Song, L., Liu, M., Liu, Z., Yang, Y., Li, J., Li, D., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.11.012 · Cited by 97
Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia
Hall, D. T., Ma, J. F., Marco, S. D., & Gallouzi, I. (2011) · Aging · doi:10.18632/aging.100358 · Cited by 98
Brocker, C. N., Yue, J., Kim, D., Qu, A., Bonzo, J. A., & Gonzalez, F. J. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00205.2016 · Cited by 93
Paquissi, F. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01195 · Cited by 95
Jin, S., Jiang, S., & Hu, A. (2018) · Sleep And Breathing · doi:10.1007/s11325-018-1625-7 · Cited by 96
Chemokines and Chemokine Receptors in the Development of NAFLD
Roh, Y., & Seki, E. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_4 · Cited by 94
Takata, A., Otsuka, M., Yoshikawa, T., Kishikawa, T., Hikiba, Y., Obi, S., Goto, T., Kang, Y. J., Maeda, S., Yoshida, H., et al. (2012) · Hepatology · doi:10.1002/hep.26011 · Cited by 92
Hamza, A. A., Heeba, G. H., Elwy, H. M., Murali, C., El‐Awady, R., & Amin, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-19492-x · Cited by 92
Jiang, J., Li, Y., Shi, Z., Wang, L., Shan, L., & Efferth, T. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153082 · Cited by 92
Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
Russo, F. P., Zanetto, A., Pinto, E., Battistella, S., Penzo, B., Burra, P., & Farinati, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010500 · Cited by 92
Jung, Y., Park, J., Kim, H., Sim, J., Youn, D., Kang, J., Lim, S., Jeong, M., Yang, W. M., Lee, S., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700231rr · Cited by 91
Parsel, S. M., Wu, E. L., Riley, C. A., & McCoul, E. D. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.10.028 · Cited by 91
Song, H., Liu, Y., Li, X., Chen, S., Xie, R., Chen, D., Gao, H., Wang, G., Cai, B., & Yang, X. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.220 · Cited by 91
Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis
George, J., Tsuchishima, M., & Tsutsumi, M. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1272-8 · Cited by 90
Videla, L. A., & Valenzuela, R. (2021) · BioFactors · doi:10.1002/biof.1797 · Cited by 91
Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Smirne, C., Croce, E., Benedetto, D. D., Cantaluppi, V., Comi, C., Sainaghi, P. P., Minisini, R., Grossini, E., & Pirisi, M. (2022) · Livers · doi:10.3390/livers2010003 · Cited by 100
Mangiferin relieves CCl4-induced liver fibrosis in mice
Zhang, L., Liu, C., Yin, L., Huang, C., & Fan, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-30582-3 · Cited by 101
Loh, K., Tam, S., Murray‐Segal, L., Huynh, K., Meikle, P. J., Scott, J. W., van Denderen, B., Chen, Z., Steel, R., LeBlond, N. D., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1279 · Cited by 89
Lennikov, A., Mirabelli, P., Mukwaya, A., Schaupper, M., Thangavelu, M., Lachota, M., Ali, Z., Jensen, L. D., & Lagali, N. (2018) · Angiogenesis · doi:10.1007/s10456-018-9594-9 · Cited by 88
Free radicals, antioxidants, nuclear factor‐E2‐related factor‐2 and liver damage
Ramos‐Tovar, E., & Muriel, P. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3880 · Cited by 91
Rex, J., Lutz, A., Faletti, L. E., Albrecht, U., Thomas, M., Bode, J. G., Borner, C., Sawodny, O., & Merfort, I. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00117 · Cited by 87
Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma
Bandiera, S., Bian, C. B., Hoshida, Y., Baumert, T. F., & Zeisel, M. B. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.09.010 · Cited by 86
The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
Puigvehí, M., Moctezuma‐Velázquez, C., Villanueva, A., & Llovet, J. M. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.05.001 · Cited by 86
Brahma, M. K., Gilglioni, E. H., Zhou, L., Trépo, E., Chen, P., & Gurzov, E. N. (2021) · Oncogene · doi:10.1038/s41388-021-01950-y · Cited by 85
Cabrera, D., Wree, A., Povero, D., Solı́s, N., Hernández, A., Pizarro, M., Moshage, H. J., Torres, J., Feldstein, A. E., Cabello‐Verrugio, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03675-z · Cited by 86
Xie, C., Li, X., Zhu, J., Wu, J., Geng, S., & Zhong, C. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.12.033 · Cited by 85
Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology
Torre, S. D. (2021) · Cells · doi:10.3390/cells10092502 · Cited by 91
Gut epithelial barrier damage caused by dishwasher detergents and rinse aids
Öğülür, İ., Pat, Y., Aydın, T., Yazıcı, D., Rückert, B., Peng, Y., Kim, J., Radzikowska, U., Westermann, P., Sokołowska, M., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.10.020 · Cited by 84
Tumor regulation of the tissue environment in the liver
Eggert, T., & Greten, T. F. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.005 · Cited by 86
Jayakumar, S., & Loomba, R. S. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15314 · Cited by 87
Zhang, W., Fang, Z., & Liu, W. (2019) · Parasites & Vectors · doi:10.1186/s13071-018-3223-8 · Cited by 86
Roghani, M., Kalantari, H., Khodayar, M. J., Khorsandi, L., Kalantar, M., Goudarzi, M., & Kalantar, H. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s237107 · Cited by 84
Flessa, C., Kyrou, I., Ansari, N. N., Kaltsas, G., Kassi, E. N., & Randeva, H. S. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30247 · Cited by 87
Loss of PDK4 switches the hepatic NF‐κB/TNF pathway from pro‐survival to pro‐apoptosis
Wu, J., Zhao, Y., Park, Y., Lee, J., Gao, L., Zhao, J., & Wang, L. (2018) · Hepatology · doi:10.1002/hep.29902 · Cited by 83
Jiang, J., Qi, L., Lv, Z., Jin, S. H., Wei, X., & Shi, F. (2019) · Antioxidants · doi:10.3390/antiox8120575 · Cited by 83
Beta-Catenin–NF-κB Interactions in Murine Hepatocytes: A Complex to Die for
Nejak‐Bowen, K. N., Kikuchi, A., & Monga, S. P. (2012) · Hepatology · doi:10.1002/hep.26042 · Cited by 83
Role of lymphocytes in liver cancer
Mossanen, J. C., & Tacke, F. (2013) · OncoImmunology · doi:10.4161/onci.26468 · Cited by 83
Reversal of myofibroblast differentiation: A review
Yang, X., Chen, B., Liu, T., & Chen, X. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.04.007 · Cited by 82
Lin, A., Wang, G., Zhao, H., Zhang, Y., Han, Q., Zhang, C., Tian, Z., & Zhang, J. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1074376 · Cited by 82
Arjinajarn, P., Chueakula, N., Pongchaidecha, A., Jaikumkao, K., Chatsudthipong, V., Mahatheeranont, S., Norkaew, O., Chattipakorn, N., & Lungkaphin, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.100 · Cited by 82
Flessa, C., Kyrou, I., Ansari, N. N., Kaltsas, G., Papavassiliou, A. G., Kassi, E. N., & Randeva, H. S. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00431-3 · Cited by 81
Kim, H., Pan, J. H., Kim, S. H., Lee, J. H., & Park, J. (2018) · Biochimie · doi:10.1016/j.biochi.2018.05.008 · Cited by 81
Jia, R., Du, J., Cao, L., Li, Y., Johnson, O., Gu, Z., Jeney, G., Xu, P., & Yin, G. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.10.084 · Cited by 80
He, M., Zhang, W., Dong, Y., Wang, L., Fang, T., Tang, W., Lv, B., Chen, G., Yang, B., Huang, P., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0490-8 · Cited by 80
OTULIN protects the liver against cell death, inflammation, fibrosis, and cancer
Damgaard, R. B., Jolin, H. E., Allison, M., Davies, S. E., Titheradge, H. L., McKenzie, A. N. J., & Komander, D. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0532-1 · Cited by 80
Trivedi, P. P., & Jena, G. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.019 · Cited by 80
Czauderna, C., Castven, D., Mahn, F. L., & Marquardt, J. U. (2019) · Cancers · doi:10.3390/cancers11081053 · Cited by 83
Pan, T., Wang, P.-W., Leu, Y., Wu, T.-H., & Wu, T.-S. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.12.028 · Cited by 79
Iron, Oxidative Stress, and Metabolic Dysfunction—Associated Steatotic Liver Disease
Gensluckner, S., Wernly, B., Datz, C., & Aigner, E. S. (2024) · Antioxidants · doi:10.3390/antiox13020208 · Cited by 82
Melatonin attenuates carbon tetrachloride–induced liver fibrosis via inhibition of necroptosis
Choi, H., Kang, J., & Lee, S. (2015) · Translational research · doi:10.1016/j.trsl.2015.04.002 · Cited by 79
Heida, A., Gruben, N., Catrysse, L., Koehorst, M., Koster, M., Kloosterhuis, N. J., Gerding, A., Havinga, R., Bloks, V. W., Bongiovanni, L., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101349 · Cited by 78
Jackson, A. F., Williams, A., Recio, L., Waters, M. D., Lambert, I. B., & Yauk, C. L. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.019 · Cited by 78
Dagorn, P. G., Foretz, M., Steinberg, G. R., Batchuluun, B., Zawistowska‐Deniziak, A., Lambooij, J. M., Guigas, B., Carling, D., Monternier, P., Moller, D. E., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1799 · Cited by 78
Liu, J.-Y., Chiang, T., Liu, C.-H., Chern, G.-G., Lin, T.-T., Gao, D.-Y., & Chen, Y. (2015) · Molecular Therapy · doi:10.1038/mt.2015.147 · Cited by 80
Wang, R., Wang, J., Song, F., Li, S., & Yuan, Y. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s159546 · Cited by 78
Cysteine cathepsins control hepatic NF-κB-dependent inflammation via sirtuin-1 regulation
Pulido, Á. D. M., de Gregorio, E., Moles, A., Tarrats, N., Tutusaus, A., Colell, A., Fernández-Checa, J. C., Morales, A., & Marı́, M. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.368 · Cited by 78
Ivashkin, V. T., Maevskaya, M. V., Жаркова, М. С., Kotovskaya, Y. V., Ткачева, О. Н., Troshina, E. A., Shestakova, M. V., Maev, I. V., Breder, V. V., Geyvandova, N. I., et al. (2022) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2022-32-4-104-140 · Cited by 86
Hodges, J. K., Sasaki, G. Y., & Bruno, R. S. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108478 · Cited by 80
Bao, C., Li, Y., Huan, L., Zhang, Y., Zhao, F., Wang, Q., Liang, L., Ding, J., Liu, L., Chen, T., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aaa8441 · Cited by 79
Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma
Liao, C.-Y., Lee, C.-C., Tsai, C., Hsueh, C.-W., Wang, C.-C., Chen, I.-H., Tsai, M.-K., Liu, M., Hsieh, A.-T., Su, K.-J., et al. (2015) · BioMed Research International · doi:10.1155/2015/840542 · Cited by 76
El-Agroudy, N. N., El‐Naga, R. N., El‐Razeq, R. A., & El‐Demerdash, E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13611 · Cited by 76
The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease
Werge, M. P., McCann, A., Galsgaard, E. D., Holst, D., Bugge, A. K., Albrechtsen, N. J. W., & Gluud, L. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051081 · Cited by 78
Li, X., Jin, Q., Yao, Q., Xu, B., Li, Z., & Tu, C. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.09.002 · Cited by 77
Ding, J., Zhao, J., Huan, L., Liu, Y., Qiao, Y., Wang, Z., Chen, Z., Huang, S., Zhao, Y., & He, X. (2020) · Hepatology · doi:10.1002/hep.31195 · Cited by 74
Smyd3-associated regulatory pathways in cancer
Giakountis, A., Moulos, P., Sarris, M. E., Hatzis, P., & Talianidis, I. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.08.008 · Cited by 76
de Mesquita, F. C., Guixé‐Muntet, S., Fernández‐Iglesias, A., Maeso‐Díaz, R., Vila, S., Hide, D., Ortega‐Ribera, M., Rosa, J. L., García‐Pagán, J. C., Bosch, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02866-y · Cited by 78
Xu, W., Yi, M., Li, Q., Zhou, W., Cong, W., Yang, Y., Ning, B., Yin, C., Huang, Z., Wang, J., et al. (2013) · Hepatology · doi:10.1002/hep.26541 · Cited by 73
A20 prevents chronic liver inflammation and cancer by protecting hepatocytes from death
Catrysse, L., Ghahremani, M., Vereecke, L., Youssef, S., Guire, C. M., Sze, M., Weber, A., Heikenwalder, M., de Bruin, A., Beyaert, R., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.154 · Cited by 71
Xiao, J., Wang, F., Liong, E. C., So, K., & Tipoe, G. L. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.09.151 · Cited by 73
Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?
Zhou, D., Luan, J., Huang, C., & Li, J. (2020) · Gut and Liver · doi:10.5009/gnl20223 · Cited by 74
Liver Injury and Disease Pathogenesis in Chronic Hepatitis C
Yamane, D., McGivern, D. R., Masaki, T., & Lemon, S. M. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-27340-7_11 · Cited by 73
Metadata
- Authors
- Luedde, T., & Schwabe, R. F.
- Affiliations
- Universitätsklinikum Aachen (DE)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Luedde, Tom
- Schwabe, Robert F.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2011-02
- Volume
- 8
- Issue
- 2
- Pages
- 108-118
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- PMC
- PMC3295539
- OpenAlex
- W1976777085
- Cited by
- 1,345
- References
- 137
- Citations by year
- 2026: 97 · 2025: 99 · 2024: 119 · 2023: 109 · 2022: 122 · 2021: 156 · 2020: 120 · 2019: 95 · 2018: 79 · 2017: 76 · 2016: 66 · 2015: 68 · 2014: 51 · 2013: 38 · 2012: 42
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u54ca126513-03)
- National Institute on Alcohol Abuse and Alcoholism (R01AA020211)
- National Cancer Institute (U54 CA126513.)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK076920)
- National Center for Complementary and Integrative Health (R21AT003878)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- NF-κB, liver fibrosis, hepatocellular carcinoma, chronic liver disease, liver cirrhosis, chronic liver injury, liver inflammation, hepatocytes, non-parenchymal liver cells, NF-κB inhibition, hepatocyte viability
- MeSH terms
- Cell Survival, Fibrosis, Carcinoma, Hepatocellular, Homeostasis, Humans, Liver, Liver Neoplasms, NF-kappa B, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review